Diseases that impact only small percentage of population are known as rare diseases. Rare disease generally occurs at younger age and are genetic, hence present throughout patient’s life. Rare diseases are also referred to as orphan disease due to lack of resources and patient population for discovering treatment.
Rare disease gene therapy includes replacing or inactivating mutated gene to fight against disease. According to the National Institute of Health (NIH), 25 million people in the U.S. are affected with 7,000 different rare diseases.
There has been shift of focus among biopharmaceutical players to develop coronavirus cure due to Covid-19, this is delaying research and development activities in rare disease gene therapy market. Halt of manufacturing activities and supply chain disruption due to trading across borders will have impact on rare disease gene therapy market growth rate.
Reduction in diagnosis and treatment adoption rate owing to decreased patient visits to healthcare facilities will reduce growth rate of rare disease gene therapy market.Increasing number of rare diseases are expected to drive the growth of rare disease gene therapy market.
Increasing collaborative research and development activities among leading biopharmaceutical innovative players is expected to fuel the growth of rare disease gene therapy market. In addition, clinical-stage development companies are allocating significant funds towards the development of the rare disease gene therapy market.
For instance, in August 2020, the U.S. based Ovid Therapeutics collaborated with Italian firm Angelini Pharma to develop, manufacture and commercialize drug gaboxadol for treatment of Angelman syndrome (rare genetic disease) in European market.
Increasing awareness among general population about available treatment options boost rare disease gene therapy market. Stringent regulatory procedure for drug approval is expected to hinder growth of rare disease gene therapy market. Risk factors associated with gene therapy will challenge rare disease gene therapy market.
Non-viral vector type gene therapy is expected to hold major revenue share for rare disease gene therapy market with increased market penetration. Based on application genetic disorder contributes higher revenue in rare disease gene therapy market. Parenteral drugs are most common type in rare disease gene therapy market.
Intravenous drugs are expected to have significant growth rate in coming decade. Hospital pharmacies is largest distribution channel in rare disease gene therapy market followed by retail pharmacies. Online pharmacies will have exponential growth with increased adoption of e-commerce in rare disease gene therapy market.
North America will continue to dominate the rare disease gene therapy market in the coming decade with a high rate of approvals and commercialization of genomic medicine. Increased awareness and availability of advanced technology propels the demand for rare disease gene therapy market in North America.
Europe holds significant share in rare disease gene therapy market with increased investments towards research and development activities. Asia-pacific is lucrative with a high growth rate in the rare disease gene therapy market during the forecast period with a large patient population in the region.
The Middle East and Africa are expected to observe the least growth in rare disease gene therapy market due to less healthcare expenditure in the region. Poor economic conditions in the Middle East and Africa make them untapped regions with fewer growth opportunities of rare disease gene therapy market.
The global rare disease gene therapy market is classified based on gene therapy, indication, route of administration, distribution channel and region.
Gene Therapy
Indication
Administration
Distribution Channel
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Rare Earth FeSiMg Nodularizers Market Size and Share Forecast Outlook 2025 to 2035
Rare-earth Barium Copper Oxide (REBCO) Wire Market Size and Share Forecast Outlook 2025 to 2035
Rare Gas Market Size and Share Forecast Outlook 2025 to 2035
Rare Sugar Market Size and Share Forecast Outlook 2025 to 2035
Rare NRG1 Fusion Market Size and Share Forecast Outlook 2025 to 2035
Competitive Overview of Rare Earth Elements Companies
Rare Earth Metals Market Demand & Trends 2024-2034
Rare Disease Clinical Trials Market Size and Share Forecast Outlook 2025 to 2035
Rare Neurological Disease Treatment Market Report – Demand, Growth & Industry Outlook 2025-2035
Rare Inflammatory Disease Treatment Market Size and Share Forecast Outlook 2025 to 2035
Industry Share Analysis for Rare Neurological Disease Treatment Providers
Rare Gastrointestinal Diseases Treatment Market Trends and Forecast 2025 to 2035
Infrared Heating Pad Market Size and Share Forecast Outlook 2025 to 2035
Infrared Thermography Market Size and Share Forecast Outlook 2025 to 2035
Infrared Thermometer Market Growth – Trends & Forecast 2025 to 2035
Infrared Search and Track (IRST) Systems Market Analysis - Growth & Forecast 2025 to 2035
Infrared Sensors Market Analysis – Growth & Trends 2025 to 2035
Infrared (IR) LEDs Market by Component by Application & Region Forecast till 2035
Infrared Imaging Market
Mid-infrared Lasers Market Analysis - Growth & Trends 2025 to 2035
Rare Disease Gene Therapy Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
